Halozyme Therapeutics, Inc. (NASDAQ:HALO) declared that it reviewed the PEGPH20 development program and deliver 2015 financial guidance through a meeting for analysts and shareholders. Dr. Helen Torley, President and CEO of the firm stated that they are committed to discovering the full potential of investigational new drug PEGPH20 which they believe may have utility in a variety of solid tumors with accumulation of high levels of hyaluronan. Halozyme Therapeutics, Inc. (NASDAQ:HALO) in last trading activity advanced 11.58% to close at $13.97. Company weekly performance is 44.77% while its quarterly performance stands at 53.52%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) is -23.16% away from its 52 week high.
Bristol-Myers Squibb Company (NYSE:BMY) announced that it has entered into an agreement with the California Institute for Biomedical Research for the development of novel small molecule anti-fibrotic drugs. The deal gives Bristol-Myers an exclusive license to develop, manufacture and commercialize the institute’s preclinical compounds resulting from the collaboration. On last trading day Bristol-Myers Squibb Company (NYSE:BMY) advanced 2.50% to close at $60.72. Its volatility for the week is 1.82% while volatility for the month is 1.92%. BMY’s sales growth for past 5 years was -1.50% and its EPS growth for past 5 years was -3.60%. Bristol-Myers Squibb Company (NYSE:BMY) monthly performance is 0.71%.
BP p.l.c. (NYSE:BP) is likely to face a major loss of hundreds of millions of dollars in earnings and dividend income from Rosneft, Russia’s state-owned oil company. The loss is mainly due to the decline in crude prices and financial turmoil that has resulted in the fall of the rouble. On Thursday shares of BP p.l.c. (NYSE:BP) closed at $36.73. Company’s sales growth for last 5 years was 1.00% and EPS growth for next 5 years is recorded as 8.30%.
Leju Holdings Ltd (NYSE:LEJU) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research report issued on Friday. They currently have a $10.20 target price on the stock. Zacks‘s price target would indicate a potential downside of 17.07% from the stock’s previous close. On Thursday shares of Leju Holdings Limited (NYSE:LEJU) closed at $12.90.
International Business Machines Corp. (NYSE:IBM) named Robert LeBlanc as senior vice president of IBM Cloud, a dedicated unit being created to speed up the company’s development of its cloud-computing business, according to a person familiar with the matter. International Business Machines Corporation (NYSE:IBM) in last trading activity increased 2.17% to close at $158.42. Company weekly performance is -1.26% while its quarterly performance stands at -15.77%. International Business Machines Corporation (NYSE:IBM) is -18.99% away from its 52 week high.